Pathophysiology, diagnosis, and management of neuroinflammation in covid-19

RL Brown, L Benjamin, MP Lunn, T Bharucha… - bmj, 2023 - bmj.com
Although neurological complications of SARS-CoV-2 infection are relatively rare, their
potential long term morbidity and mortality have a significant impact, given the large …

Neurological complications of critically ill COVID-19 patients

R Sonneville, NS Dangayach… - Current Opinion in …, 2023 - journals.lww.com
Neurological complications of critically ill COVID-19 patien... : Current Opinion in Critical Care
Neurological complications of critically ill COVID-19 patients : Current Opinion in Critical Care …

[HTML][HTML] Risks of neurological and psychiatric sequelae 2 years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other …

H Ley, Z Skorniewska, PJ Harrison, M Taquet - Brain, Behavior, and …, 2023 - Elsevier
The association between COVID-19 and subsequent neurological and psychiatric disorders
is well established. However, two important questions remain unanswered. First, what are …

Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease—Preliminary Data

F Biamonte, A Re, BO Balzamino, G Ciasca… - Journal of Personalized …, 2022 - mdpi.com
COVID-19 continues to afflict the global population, causing several pathological diseases
and exacerbating co-morbidities due to SARS-CoV-2's high mutation. Recent interest has …

[HTML][HTML] Improving neuropsychological rehabilitation for COVID-19 patients

CN Widmann, J Kolano… - Zeitschrift für …, 2023 - econtent.hogrefe.com
Cognitive sequelae after recovery from an initial COVID-19 disease are present in a subset
of affected individuals, coalescing around several important issues such as effects of age …

An FDA-approved assay platform can detect biomarkers of neuronal and glial injury in the blood of COVID-19 patients

AV Glushakov, AY Vittor, L Lewis, S House, ML Bartlett… - medRxiv, 2024 - medrxiv.org
Employing assays approved by the US Food and Drug Administration (FDA) to assist in
detection of brain injury in mild traumatic brain injury (TBI) patients, this study demonstrated …